Marghi Merzenich is the VP of Content for Posit Science. For over a decade, she's been helping to make complex neuroscience concepts more accessible to BrainHQ's users and partners.

Study: Most MS Patients Don’t Stick with Drug Treatment

Multiple Sclerosis (MS) is a chronic, debilitating disease that attacks the neurological system, affecting both body and brain function. A recent study of Canadian MS patients revealed that fewer than half of them consistently use MS medications for 2+ years.  The drugs, known as DMDs (disease-modifying drugs) have been proven to slow the progress of…

After Chemotherapy, Brain Can Be Impaired For 5+ Years

The Fred Hutchinson Cancer Research Center in Seattle just released results of a recent study. The researchers were looking at “chemobrain,” a type of cognitive impairment that occurs following chemotherapy treatment. The study showed that tpost-chemo cognitive impairment may be longer lasting and more severe than generally believed. This finding is important because even today, some…

Concussions and Hockey – What Can Be Done?

This past Super Bowl weekend, I wrote about some interesting connections between neuroscience and football, including a variety of statistics and opinions about brain injuries and football. Now that football season is over, I’ve noticed an increasing number of headlines about brain injuries in hockey players. Recent research in Canadian Medical Association Journal (CMAJ) found…

Brain Plasticity & Brain Fitness with Dr. Michael Merzenich

A few days ago, we hosted a Q&A session on Facebook about brain plasticity and brain fitness with Posit Science founder Dr. Michael Merzenich. For those who missed the discussion and prefer to read it in transcript form, I’ve re-posted it here. Question: I would love to know what Dr. Merzenich thinks about brain plasticity…